VVM

Versant Venture Management Portfolio holdings

AUM $82.1M
This Quarter Return
+58.68%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$105M
AUM Growth
–
Cap. Flow
+$105M
Cap. Flow %
100%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
$45.6M
2
FPRX
Five Prime Therapeutics, Inc.
FPRX
$29.5M
3
AKAO
Achaogen, Inc.
AKAO
$16.7M
4
CBAY
Cymabay Therapeutics
CBAY
$10.3M
5
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$2.44M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 81.68%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
$45.6M 43.63% +814,833 New +$45.6M
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$29.5M 28.2% +1,092,152 New +$29.5M
AKAO
3
DELISTED
Achaogen, Inc.
AKAO
$16.7M 15.99% +1,281,152 New +$16.7M
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$10.3M 9.86% +1,048,601 New +$10.3M
KYTH
5
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$2.44M 2.33% +70,376 New +$2.44M